RIA
IONS icon

Realta Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Realta Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,487
Closed -$324K – 345
2020
Q2 		$324K Sell
5,487
-4,550
-45% -$253K 0.11% 238
2020
Q1 		$475K Sell
10,037
-1,375
-12% -$76.6K 0.2% 139
2019
Q4 		$729K Buy
11,412
+424
+4% +$25.3K 0.2% 126
2019
Q3 		$654K Buy
10,988
+965
+10% +$62.9K 0.18% 130
2019
Q2 		$640K Buy
10,023
+172
+2% +$12.2K 0.18% 142
2019
Q1 		$795K Buy
+9,851
New +$635K 0.36% 72

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Realta Investment Advisors's IONS Position: Q3 2020 in Review

Realta Investment Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 5,487 shares — an estimated $324K sold.

Realta Investment Advisors first reported a position in IONS in Q1 2019 and held it in 6 quarters. The position peaked at $795K in Q1 2019. 367 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

  • Realta Investment Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 5,487 Ionis Pharmaceuticals shares in Q3 2020, an estimated $324K.
  • Realta Investment Advisors first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 6 quarters.
  • Realta Investment Advisors's Ionis Pharmaceuticals position peaked at $795K in Q1 2019.
  • 367 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on Realta Investment Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.